ACADIAN ASSET MANAGEMENT LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$57,000
-10.9%
5,5620.0%0.00%
Q2 2022$64,000
-14.7%
5,562
-7.4%
0.00%
Q1 2022$75,000
-59.0%
6,008
-61.8%
0.00%
-100.0%
Q4 2021$183,000
-95.4%
15,729
-94.8%
0.00%
-93.3%
Q3 2021$3,976,000
-53.8%
304,857
-54.4%
0.02%
-53.1%
Q2 2021$8,599,000
+242.5%
668,161
+197.4%
0.03%
+220.0%
Q1 2021$2,511,000
-67.8%
224,636
-67.2%
0.01%
-66.7%
Q4 2020$7,800,000
+8.9%
684,891
-13.9%
0.03%0.0%
Q3 2020$7,160,000
+34.9%
795,804
+54.7%
0.03%
+30.4%
Q2 2020$5,308,000
+26440.0%
514,332
+26289.5%
0.02%
Q1 2020$20,0001,9490.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders